AIM/NCYT (AIM/NCYT)

London Stock Exchange AIM: AIM/NCYT · GBX

GBX 36.0

-1.75 (-4.6%)· Recorded snapshot

Market cap	26.2M
Revenue (ttm)	21.8M
Net income (ttm)	-22.3M
EPS (ttm)	-GBX 0.30
Volume	28,608

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.8M
Net income (ttm): -22.3M
EPS (ttm): -GBX 0.30
Market cap: 26.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-75.2

P25 n/aP50 n/aP75 n/a

ROIC-54.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/NCYT indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

GBP

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	France
Country code	UK
Earnings date	2026-09-30
Employees	228
Employees change	-18
Employees growth	-7.69%
Enterprise value	GBX 27.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Medical Devices
Is primary listing	No
ISIN number	FR0010397232
Last earnings date	2026-09-30
Last refreshed	2026-10-28
Market cap	GBX 26.2M
Next earnings date	2027-04-30
Price	GBX 36.00
Price currency	GBX
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	aim/NCYT
Website	https://www.novacyt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-84.72%
EV/EBITDA	7.58x
EV/Sales	1.36x
FCF / EV yield	-29.54%
FCF yield	-30.92%
Industry forward P/E	13.68x
Industry P/E	21.46x
P/B ratio	1.47x
P/S ratio	1.26x
Price / tangible book value	2.86x
Price/EBITDA ratio	8.71x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-50.31%
EBITDA margin	14.48%
Gross margin	52.52%
Operating margin	-50.31%
Pretax margin	-119.91%
Profit margin	-102.49%
Profit per employee	GBX -97,961
Revenue per employee	GBX 95,583
ROA	-13.62%
ROA (5Y)	-5.87%
ROCE	-35.03%
ROE	-75.24%
ROE (5Y)	-33.66%
ROIC	-54.7%
ROIC (5Y)	-25.34%
SBC / revenue	1.55%
Tax / revenue	-17.1%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
Gross profit growth	2%
Gross profit growth (Q)	-1.06%
Gross profit growth 3Y	49.86%
Gross profit growth 5Y	-43.31%
Net income growth quarters	2
Net income growth years	1
Revenue growth	12.05%
Revenue growth (Q)	18.01%
Revenue growth (QoQ)	12.91%
Revenue growth 10Y	11.83%
Revenue growth 3Y	40.42%
Revenue growth 5Y	-39.38%
Revenue growth quarters	6
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -210,000
Depreciation and amortization	GBX 14.1M
EBIT	GBX -11M
EBITDA	GBX 3.2M
EPS	GBX -0.30
Financing cash flow	GBX -1.1M
Free cash flow	GBX -8.5M
Free cash flow minus SBC	GBX -8.8M
Gross profit	GBX 11.4M
Income taxes	GBX -3.7M
Investing cash flow	GBX -5.4M
Net borrowing	GBX -1.6M
Net cash flow	GBX -14.8M
Net income	GBX -22.3M
Operating cash flow minus SBC	GBX -8.6M
Operating income	GBX -11M
Revenue	GBX 21.8M
Stock-based compensation	GBX 338,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.27
Book value per share	GBX 0.26
Debt / EBITDA	2.62
Debt / equity	0.55
Goodwill	GBX 4.4M
Interest coverage	-19.24
Long-term assets	GBX 17.7M
Long-term liabilities	GBX 12.6M
Net cash (debt)	GBX -1.3M
Net cash / market cap	-4.8%
Net debt / EBITDA	0.42
Net debt / equity	0.07
Piotroski F-Score	2
Property, plant and equipment	GBX 8.5M
Shareholders' equity	GBX 18.7M
Tangible book value	GBX 9.6M
Tangible book value per share	GBX 0.13
Total assets	GBX 37.7M
Total cash	GBX 8.9M
Total debt	GBX 10.2M
Total liabilities	GBX 19M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	GBX 20M
Current liabilities	GBX 6.4M
Current ratio	3.14
Inventory turnover	2.76
Net working capital	GBX 5.7M
Quick ratio	2.19
Working capital	GBX 13.6M
Working capital turnover	1.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.79%
Shareholder yield	-0.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	GBX 39.51
1D price change	-4.64%
1M price change	-19.01%
1M total return	-19.01%
1W price change	-8.4%
1W total return	-8.4%
1Y price change	-12.83%
1Y return CAGR	-12.84%
1Y total return	-12.83%
20-day SMA	GBX 39.44
200-day SMA	GBX 38.20
3M price change	-3.74%
3M total return	-3.74%
3Y price change	-13.2%
3Y return CAGR	-4.61%
3Y total return	-13.2%
50-day SMA	GBX 41.60
50-day SMA vs 200-day SMA	50over200
52-week high	GBX 86.00
52-week high date	2026-05-12
52-week low	GBX 26.60
52-week low date	2026-05-05
5Y price change	-85.5%
5Y return CAGR	-32.04%
5Y total return	-85.5%
6M price change	9.09%
6M total return	9.09%
All-time high	GBX 1,270.00
All-time high date	2020-10-26
All-time low	GBX 6.03
All-time low date	2019-10-14
Average true range (ATR)	GBX 1.84
Average volume	117.2K
Change from 52-week high	-58.14%
Change from 52-week low	35.34%
Change from all-time high	-97.17%
Change from all-time low	497.01%
Change from open	-2.96%
Day's gap	-1.72%
Dollar volume	GBX 1M
High price	GBX 37.97
Low price	GBX 36.00
Monthly RSI	44.34
Open price	GBX 37.10
Position in 52-week range	0%
Previous close	GBX 37.75
Price vs 150-day SMA	-8.88%
Price vs 20-day SMA	-8.72%
Price vs 200-day SMA	-5.76%
Price vs 50-day SMA	-13.47%
Relative volume	0.24
RSI	33.07
Sharpe ratio	0.3
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	-0.01
Sortino ratio	0.71
Sortino ratio (3Y)	0.63
Sortino ratio (5Y)	0.05
Volume	28.6K
Weekly RSI	44.91
YTD price change	1.55%
YTD total return	1.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72.3M
Shares change (QoQ)	1.58%
Shares change (YoY)	0.79%
Shares held by insiders	0.24%

Deeper analysis on AIM/NCYT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/NCYT report

Is a complete AIM/NCYT research report available?

No complete published report is available for aim/NCYT (AIM/NCYT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/NCYT (AIM/NCYT)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/NCYT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/NCYT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/NCYT

Frequently asked questions